Ken Griffin Options Holdings

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Options Holdings Table

Stock Option Type Value Options Held Last Trade Trade History
NVS
Novartis Ag

Healthcare
PUT
$12.4 Million
108K
Q3 2024
Added 30.79%
NVAX
Novavax Inc

Healthcare
CALL
$13.6 Million
1.07M
Q3 2024
Reduced 14.77%
NVAX
Novavax Inc

Healthcare
PUT
$15.2 Million
1.2M
Q3 2024
Reduced 14.77%
NVCR
Novo Cure LTD

Healthcare
CALL
$2.61 Million
167K
Q3 2024
Added 62.79%
NVCR
Novo Cure LTD

Healthcare
PUT
$1.11 Million
71.3K
Q3 2024
Added 62.79%
Nrx Pharmaceuticals Inc
CALL
$0
35.3K
Q3 2024
Added 17.65%
Nrx Pharmaceuticals Inc
PUT
$0
1K
Q3 2024
Added 17.65%
NUS
Nu Skin Enterprises, Inc.

Consumer Defensive
CALL
$79,000
10.8K
Q3 2024
Reduced 44.03%
NUS
Nu Skin Enterprises, Inc.

Consumer Defensive
PUT
$55,000
7.5K
Q3 2024
Reduced 44.03%
NRIX
Nurix Therapeutics, Inc.

Healthcare
CALL
$365,000
16.3K
Q3 2024
Reduced 71.19%
SMR
Nuscale Power Corp

Industrials
CALL
$6.61 Million
571K
Q3 2024
Added 99.06%
SMR
Nuscale Power Corp

Industrials
PUT
$7.59 Million
655K
Q3 2024
Added 99.06%
NTNX
Nutanix, Inc.

Technology
PUT
$12 Million
203K
Q3 2024
Reduced 35.11%
NTR
Nutrien Ltd.

Basic Materials
CALL
$20.4 Million
424K
Q3 2024
Reduced 7.43%
NUVL
Nuvalent, Inc.

Healthcare
CALL
$1.13 Million
11K
Q3 2024
Added 1081.82%
NUVL
Nuvalent, Inc.

Healthcare
PUT
$13.3 Million
130K
Q3 2024
Added 1081.82%
NUVB
Nuvation Bio Inc.

Healthcare
CALL
$7,000
3.2K
Q3 2024
Added 1418.46%
NUVB
Nuvation Bio Inc.

Healthcare
PUT
$227,000
98.7K
Q3 2024
Added 1418.46%
NVEI
Nuvei Corp

Technology
CALL
$497,000
14.9K
Q3 2024
Added 30.34%
NVEI
Nuvei Corp

Technology
PUT
$773,000
23.2K
Q3 2024
Added 30.34%
NVEE
Nv5 Global, Inc.

Industrials
CALL
$102,000
1.1K
Q3 2024
Reduced 15.38%
NVEE
Nv5 Global, Inc.

Industrials
PUT
$93,000
1K
Q3 2024
Reduced 15.38%
NVT
N Vent Electric PLC

Industrials
CALL
$3.12 Million
44.4K
Q3 2024
Added 137.37%
NVT
N Vent Electric PLC

Industrials
PUT
$4.69 Million
66.7K
Q3 2024
Added 137.37%
OI
O I Glass, Inc.

Consumer Cyclical
CALL
$1.16 Million
88.6K
Q3 2024
Reduced 59.89%
OI
O I Glass, Inc.

Consumer Cyclical
PUT
$297,000
22.7K
Q3 2024
Reduced 59.89%
Oaktree Specialty Lending CO
CALL
$0
24.1K
Q3 2024
Reduced 2.3%
Oaktree Specialty Lending CO
PUT
$0
17K
Q3 2024
Reduced 2.3%
OTLY
Oatly Group Ab

Consumer Defensive
CALL
$259,000
306K
Q3 2024
Reduced 25.07%
OTLY
Oatly Group Ab

Consumer Defensive
PUT
$92,000
109K
Q3 2024
Reduced 25.07%
OBE
Obsidian Energy Ltd.

Energy
CALL
$167,000
30.2K
Q3 2024
Reduced 21.13%
OBE
Obsidian Energy Ltd.

Energy
PUT
$169,000
30.6K
Q3 2024
Reduced 21.13%
Ocean Biomedical Inc
CALL
$0
70.9K
Q3 2024
Added 200.0%
Ocean Biomedical Inc
PUT
$0
600
Q3 2024
Added 200.0%
OPTT
Ocean Power Technologies, Inc.

Industrials
CALL
$3,000
18.9K
Q3 2024
New holding
OPTT
Ocean Power Technologies, Inc.

Industrials
PUT
$0
4K
Q3 2024
New holding
OII
Oceaneering International Inc

Energy
CALL
$390,000
15.7K
Q3 2024
Reduced 19.7%
OII
Oceaneering International Inc

Energy
PUT
$263,000
10.6K
Q3 2024
Reduced 19.7%
OCFC
Oceanfirst Financial Corp

Financial Services
CALL
$172,000
9.3K
Q3 2024
Reduced 95.0%
OCFC
Oceanfirst Financial Corp

Financial Services
PUT
$3,000
200
Q3 2024
Reduced 95.0%
OCGN
Ocugen, Inc.

Healthcare
CALL
$345,000
349K
Q3 2024
Reduced 20.04%
OCGN
Ocugen, Inc.

Healthcare
PUT
$129,000
131K
Q3 2024
Reduced 20.04%
OCUL
Ocular Therapeutix, Inc

Healthcare
CALL
$340,000
39.1K
Q3 2024
Reduced 23.74%
OCUL
Ocular Therapeutix, Inc

Healthcare
PUT
$869,000
99.9K
Q3 2024
Reduced 23.74%
OCUP
Ocuphire Pharma, Inc.

Healthcare
CALL
$18,000
14.1K
Q3 2024
Reduced 60.0%
OCUP
Ocuphire Pharma, Inc.

Healthcare
PUT
$1,000
800
Q3 2024
Reduced 60.0%
Oddity Tech LTD
CALL
$0
10.6K
Q3 2024
Added 54.12%
Oddity Tech LTD
PUT
$0
512K
Q3 2024
Added 54.12%
OMEX
Odyssey Marine Exploration Inc

Industrials
CALL
$191,000
231K
Q3 2024
Added 484.36%
Ken Griffin

Ken Griffin

Ken Griffin is the founder and CEO of Citadel Advisors, a successful investment firm that uses technology and data-driven approaches to investing. Griffin is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.
Track Ken Griffin's portfolio

Summary

  • Portfolio
  • No. of Stocks 16,902
  • Current Value $505 Billion
  • Prior Value $483 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 1,111 stocks
  • Additional Purchases 2,227 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2,336 stocks
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email